ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

ALVR AlloVir Inc

0,798
-0,0085 (-1,05%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
AlloVir Inc ALVR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,0085 -1,05% 0,798 06:00:03
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,81 0,7801 0,81 0,798 0,8065
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
14/3/202411:10PRNUSClass Action Filed Against AlloVir, Inc. (ALVR) Seeking..
07/3/202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
22/2/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202411:45PRNUSClass Action Filed Against AlloVir, Inc. (ALVR) Seeking..
22/2/202402:22EDGAR2Form 144 - Report of proposed sale of securities
20/2/202423:00EDGAR2Form 144 - Report of proposed sale of securities
15/2/202422:30EDGAR2Form RW - Registration Withdrawal Request
12/2/202422:34EDGAR2Form 8-K - Current report
09/2/202411:45PRNUSShareholders that lost money on AlloVir, Inc.(ALVR) Urged to..
06/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:00EDGAR2Form 144 - Report of proposed sale of securities
02/2/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
25/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202402:30EDGAR2Form 144 - Report of proposed sale of securities
09/1/202418:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/1/202418:29EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:14IHMARKETNEWSWall Street Highlights: Google Rejects Union Negotiations,..
05/1/202400:00EDGAR2Form 144 - Report of proposed sale of securities
04/1/202423:21EDGAR2Form 8-K - Current report
22/12/202313:07EDGAR2Form 8-K - Current report
22/12/202313:00GLOBEAlloVir Provides Updates on Phase 3 Clinical Development..
21/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202323:00EDGAR2Form 144 - Report of proposed sale of securities
17/11/202323:30EDGAR2Form 144 - Report of proposed sale of securities
16/11/202313:00BWAlloVir to Present at the Piper Sandler 35th Annual..
02/11/202321:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202313:11EDGAR2Form 8-K - Current report
02/11/202312:00BWAlloVir Reports Third Quarter 2023 Financial Results
23/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202323:00EDGAR2Form 144 - Report of proposed sale of securities
05/10/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202323:49EDGAR2Form 144 - Report of proposed sale of securities
28/8/202313:00BWAlloVir to Present at Upcoming Investor Conferences
21/8/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202323:00EDGAR2Form 144 - Report of proposed sale of securities
17/8/202323:07EDGAR2Form 144 - Report of proposed sale of securities
03/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202313:34EDGAR2Form 8-K - Current report
03/8/202313:00BWAlloVir Reports Second Quarter 2023 Financial Results
21/7/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202301:23EDGAR2Form 144 - Report of proposed sale of securities
12/7/202313:41IHMARKETNEWSWednesday’s Wall Street Highlights: Nvidia, VMware,..
06/7/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202323:49EDGAR2Form 144 - Report of proposed sale of securities
05/7/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/6/202303:20BWAlloVir Announces Pricing of Public Offering of Common Stock
21/6/202322:18BWAlloVir Announces Proposed Public Offering of Common Stock
05/6/202313:00BWAlloVir Presents Positive Final Results From A Phase 2..

Dernières Valeurs Consultées

Delayed Upgrade Clock